Advertisement
Letter to the Editor| Volume 50, ISSUE 3, P236-239, June 2008

Download started.

Ok

Serum BAFF and APRIL levels in patients with alopecia areata

      Alopecia areata (AA) is regarded as a tissue-specific autoimmune disease of hair follicles. CD8+ T cells are considered to act as the effector cells with help from CD4+ T cells [
      • Alexis A.F.
      • Dudda-Subramanya R.
      • Sinha A.A.
      Alopecia areata: autoimmune basis of hair loss.
      ]. Various autoantibodies have also been found in the sera [
      • Kuwano Y.
      • Fujimoto M.
      • Watanabe R.
      • et al.
      Serum anti-Fcgamma receptor autoantibodies in patients with alopecia areata.
      ,
      • Tobin D.J.
      • Hann S.K.
      • Song M.S.
      • Bystryn J.C.
      Hair follicle structures targeted by antibodies in patients with alopecia areata.
      ]. These antibodies may not play a primary direct role in AA pathogenesis; however, the production of these antibodies suggests that B cells are excessively activated in AA.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Dermatological Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Alexis A.F.
        • Dudda-Subramanya R.
        • Sinha A.A.
        Alopecia areata: autoimmune basis of hair loss.
        Eur J Dermatol. 2004; 14: 364-370
        • Kuwano Y.
        • Fujimoto M.
        • Watanabe R.
        • et al.
        Serum anti-Fcgamma receptor autoantibodies in patients with alopecia areata.
        Arch Dermatol Res. 2006; 298: 493-498
        • Tobin D.J.
        • Hann S.K.
        • Song M.S.
        • Bystryn J.C.
        Hair follicle structures targeted by antibodies in patients with alopecia areata.
        Arch Dermatol. 1997; 133: 57-61
        • Moore P.A.
        • Belvedere O.
        • Orr A.
        • et al.
        BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator.
        Science. 1999; 285: 260-263
        • Mackay F.
        • Schneider P.
        • Rennert P.
        • Browning J.
        BAFF AND APRIL: a tutorial on B cell survival.
        Annu Rev Immunol. 2003; 21: 231-264
        • Kalled S.L.
        Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production.
        Semin Immunol. 2006; 18: 290-296
        • Mackay F.
        • Leung H.
        The role of the BAFF/APRIL system on T cell function.
        Semin Immunol. 2006; 18: 284-289
        • Xu W.
        • He B.
        • Chiu A.
        • et al.
        Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI.
        Nat Immunol. 2007; 8: 294-303
        • Asashima N.
        • Fujimoto M.
        • Watanabe R.
        • Nakashima H.
        • Yazawa N.
        • Okochi H.
        • Tamaki K.
        Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris.
        Br J Dermatol. 2006; 155: 330-336
        • Watanabe R.
        • Fujimoto M.
        • Yazawa N.
        • et al.
        Increased serum levels of a proliferation-inducing ligand in patients with bullous pemphigoid.
        J Dermatol Sci. 2007; 46: 53-60